Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nanomedicine

• Publication date

  2013-11-26

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.2217/nnm.12.209PMID 23631502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Central nervous system cancers.

  2011cited by this paper
• Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.

  2010cited by this paper
• Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

  2010cited by this paper
• Near-infrared quantum dots as optical probes for tumor imaging.

  2010cited by this paper
• Future of convection-enhanced delivery in the treatment of brain tumors.

  2010cited by this paper
• Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

  2010cited by this paper
• Novel drug delivery strategies in neuro-oncology

  2009cited by this paper
• HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery.

  2008cited by this paper
• Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

  2008cited by this paper
• Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo.

  2008cited by this paper
• Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts.

  2007cited by this paper
• Drug Targeting to the Brain

  2007cited by this paper
• Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.

  2007cited by this paper
• Ligand-targeted liposomal therapies of neuroblastoma.

  2007cited by this paper
• Sentinel lymph node imaging using quantum dots in mouse tumor models.

  2007cited by this paper
• Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel

  2007cited by this paper
• Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.

  2007cited by this paper
• Quantum Dots in Biological and Biomedical Research: Recent Progress and Present Challenges

  2006cited by this paper
• Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy.

  2006cited by this paper
• Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

  2006cited by this paper
• Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.

  2006cited by this paper
• Real-time Imaging and Quantification of Brain Delivery of Liposomes

  2006cited by this paper
• Real-time, Image-Guided, Convection-Enhanced Delivery of Interleukin 13 Bound to Pseudomonas Exotoxin

  2006cited by this paper
• Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.

  2006cited by this paper
• Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents.

  2005cited by this paper
• Quantum dot bioconjugates for imaging, labelling and sensing

  2005cited by this paper
• Surface modification to reduce nonspecific binding of quantum dots in live cell assays.

  2005cited by this paper
• Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.

  2005cited by this paper
• Quantum dots as cellular probes.

  2005cited by this paper
• Development of ligand-targeted liposomes for cancer therapy

  2004cited by this paper
• Extensive Distribution of Liposomes in Rodent Brains and Brain Tumors Following Convection-Enhanced Delivery

  2004cited by this paper
• Use of quantum dots for live cell imaging

  2004cited by this paper
• Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging

  2004cited by this paper
• Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

  2002cited by this paper
• Convection-enhanced delivery of macromolecules in the brain.

  1994cited by this paper

• CAR-T and Nanotechnology: A Comparative Perspective on Autoimmune Disease and Cancer

  2025cites this paper
• A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials

  2023cites this paper
• Quantum dots: The cutting-edge nanotheranostics in brain cancer management.

  2022cites this paper
• Construction of nanomaterials as contrast agents or probes for glioma imaging

  2021cites this paper
• Nanoparticle brain delivery: a guide to verification methods.

  2020cites this paper
• c(RGDyk)-modified nanoparticles encapsulating quantum dots as a stable fluorescence probe for imaging-guided surgical resection of glioma under the auxiliary UTMD

  2020cites this paper
• Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors

  2020cites this paper
• Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma.

  2020cites this paper
• Nanostructured Therapeutic Systems of PUFA'S for the Treatment of Glioblastoma Multiforme.

  2020cites this paper
• Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management

  2020cites this paper
• Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.

  2019cites this paper
• Nanoformulations for glioblastoma multiforme: a new hope for treatment.

  2019cites this paper
• Brain local delivery strategy

  2019cites this paper
• Convection-enhanced Drug Delivery for Glioblastoma: A Systematic Review Focused on Methodological Differences in the Use of the Convection-enhanced Delivery Method

  2019cites this paper
• Self‐assembled amphiphilic core‐shell nanocarriers in line with the modern strategies for brain delivery

  2017cites this paper
• Design of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical application

  2017cites this paper
• New Perspectives in Glioblastoma: Nanoparticles-based Approaches.

  2017cites this paper
• Targeted and theranostic applications for nanotechnologies in medicine

  2017cites this paper
• Photoluminescent nanoplatforms in biomedical applications

  2016cites this paper
• Advances in Neurotherapeutic Delivery Technologies

  2015cites this paper
• The Fluoride Host: Nucleation, Growth, and Upconversion of Lanthanide‐Doped Nanoparticles

  2015cites this paper
• The engineering of doxorubicin-loaded liposome-quantum dot hybrids for cancer theranostics

  2014cites this paper
• Continuing progress toward controlled intracellular delivery of semiconductor quantum dots

  2014cites this paper
• Nanosurgical resection of malignant brain tumors: beyond the cutting edge.

  2014cites this paper